Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and ...

An expert explained a potential side effect associated with treatment consisting of Itovebi for breast cancer.

Regarding patients with HER2-negative, estrogen receptor (ER)-positive breast cancer, the phase 3 KEYNOTE-756 study is ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

The FDA accepted a supplemental biologics license application for Opdivo plus Yervoy as a first-line treatment for some adult ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

My relationship with lymphedema has been more complicated than my relationship with the mastectomy. While I am less stressed ...